Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep
暂无分享,去创建一个
J. Santamaría | S. Irusta | L. Luján | P. Pinczowski | M. Gimeno | Marta Pérez | E. Salazar | N. Álvarez | N. Insausti | Yerzol Cortés | L. Figueras | I. Cuartielles | M. Vila | E. Fantova | J. Chapullé | N. Alvarez
[1] Deming Zhao,et al. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation , 2012, Journal of Neuroinflammation.
[2] Jicheng Li,et al. Progress of Research in Cell‐in‐Cell Phenomena , 2012, Anatomical record.
[3] E. Israeli. Gulf War Syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA) , 2012, Lupus.
[4] R. Gherardi,et al. Macrophagic myofasciitis: characterization and pathophysiology , 2012, Lupus.
[5] C. Shaw,et al. Aluminum vaccine adjuvants: are they safe? , 2011, Current medicinal chemistry.
[6] Y. Shoenfeld,et al. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. , 2011, Journal of autoimmunity.
[7] J. A. García de Jalón,et al. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines , 2010, Veterinary Record.
[8] Christopher Exley,et al. The immunobiology of aluminium adjuvants: how do they really work? , 2010, Trends in immunology.
[9] R. Koike,et al. Cryopyrin-associated periodic syndromes: background and therapeutics , 2010, Modern rheumatology.
[10] P. Brugières,et al. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. , 2009, Journal of inorganic biochemistry.
[11] M. S. Petrik,et al. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. , 2009, Journal of inorganic biochemistry.
[12] Vijay Kumar,et al. Aluminium neurotoxicity: neurobehavioural and oxidative aspects , 2009, Archives of Toxicology.
[13] P. Marrack,et al. Towards an understanding of the adjuvant action of aluminium , 2009, Nature Reviews Immunology.
[14] Christopher Exley,et al. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. , 2009, Medical hypotheses.
[15] D. Cordato,et al. Post-vaccination encephalomyelitis: Literature review and illustrative case , 2008, Journal of Clinical Neuroscience.
[16] Richard A. Flavell,et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.
[17] G. Trendelenburg. Acute Neurodegeneration and the Inflammasome: Central Processor for Danger Signals and the Inflammatory Response? , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] W. Egan,et al. Corrigendum to “Aluminum salts in vaccines—US perspective” [Vaccine 20 (Suppl. 2) (2002) S18–S23] , 2002 .
[19] Paul Richman,et al. Aluminum salts in vaccines--US perspective. , 2002, Vaccine.
[20] F. Authier,et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. , 2001, Brain : a journal of neurology.
[21] J. Cummings,et al. Equine motor neuron disease. , 1997, The Veterinary record.
[22] M. Ehrenfeld,et al. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. , 1999, The Journal of rheumatology.